Morgan Stanley Lowers Arcus Biosciences (NYSE:RCUS) Price Target to $25.00
Arcus Biosciences (NYSE:RCUS – Free Report) had its price target lowered by Morgan Stanley from $36.00 to $25.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the stock. Barclays upped their price target […]
Arcus Biosciences (NYSE:RCUS – Free Report) had its price target lowered by Morgan Stanley from $36.00 to $25.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other equities analysts also recently weighed in on the stock. Barclays upped their price target […]
